Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L1ME
|
|||
| Former ID |
DNC014230
|
|||
| Drug Name |
H-Phe-NH2
|
|||
| Synonyms |
5241-58-7; Phenylalanine amide; (S)-2-amino-3-phenylpropanamide; L-Phenylalanine amide; phenylalaninamide; (2S)-2-amino-3-phenylpropanamide; Phe-NH2; L-Phe-NH2; Phenh2; UNII-PV9T9B2S11; CHEMBL350320; PV9T9B2S11; CHEBI:21371; AK-46083; phenylalanylamide; L-phenylalanineamide; Benzenepropanamide, alpha-amino-, (alphaS)-; DL-Phenylalanine amide; 2-Amino-3-phenyl-propionamide; phenylalanine imine; (S)-phenylalaninamide; Benzenepropanamide, alpha-amino-, (S)-; H-L-Phe-NH2; AC1L9IEO; SCHEMBL244302
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H12N2O
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CC(C(=O)N)N
|
|||
| InChI |
1S/C9H12N2O/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H2,11,12)/t8-/m0/s1
|
|||
| InChIKey |
OBSIQMZKFXFYLV-QMMMGPOBSA-N
|
|||
| CAS Number |
CAS 5241-58-7
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:21371
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Substance-P receptor (TACR1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Calcium signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Measles | ||||
| Panther Pathway | CCKR signaling map ST | |||
| Reactome | G alpha (q) signalling events | |||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| Spinal Cord Injury | ||||
| Peptide GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of dipeptides with high affinity to the specific binding site for substance P1-7. J Med Chem. 2010 Mar 25;53(6):2383-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.